Cargando…
Nephrogenic Systemic Fibrosis in Denmark– A Nationwide Investigation
BACKGROUND: Nephrogenic systemic fibrosis is a debilitating and painful disorder with an increased stimulation of the connective tissue in the skin and systemic tissues. The disease is associated with exposure to gadolinium-based contrast agent used in magnetic resonance imaging in patients with ren...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3857209/ https://www.ncbi.nlm.nih.gov/pubmed/24349178 http://dx.doi.org/10.1371/journal.pone.0082037 |
_version_ | 1782295128986091520 |
---|---|
author | Elmholdt, Tina R. Olesen, Anne B. B. Jørgensen, Bettina Kvist, Stinne Skov, Lone Thomsen, Henrik S. Marckmann, Peter Pedersen, Michael |
author_facet | Elmholdt, Tina R. Olesen, Anne B. B. Jørgensen, Bettina Kvist, Stinne Skov, Lone Thomsen, Henrik S. Marckmann, Peter Pedersen, Michael |
author_sort | Elmholdt, Tina R. |
collection | PubMed |
description | BACKGROUND: Nephrogenic systemic fibrosis is a debilitating and painful disorder with an increased stimulation of the connective tissue in the skin and systemic tissues. The disease is associated with exposure to gadolinium-based contrast agent used in magnetic resonance imaging in patients with renal impairment. METHODS: The prevalence of nephrogenic systemic fibrosis has so far never been determined at a national level. In 2009, Denmark was the first country to design a guideline for the tracing of nephrogenic systemic fibrosis patients. The aim of this paper is to communicate the main findings of this quest. RESULTS: The outcome of the nationwide investigation revealed that Denmark had 65 patients with nephrogenic systemic fibrosis and thereby the highest prevalence of nephrogenic systemic fibrosis worldwide with 65 per 5.6 million inhabitants, or 12 per million. CONCLUSIONS: The nationwide investigation in Denmark revealed the highest prevalence of NSF worldwide. This may be rooted in a high level of awareness of NSF both among doctors, politicians and, not least, the media, combined with the fact that a nationwide NSF investigation was initiated. |
format | Online Article Text |
id | pubmed-3857209 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-38572092013-12-13 Nephrogenic Systemic Fibrosis in Denmark– A Nationwide Investigation Elmholdt, Tina R. Olesen, Anne B. B. Jørgensen, Bettina Kvist, Stinne Skov, Lone Thomsen, Henrik S. Marckmann, Peter Pedersen, Michael PLoS One Research Article BACKGROUND: Nephrogenic systemic fibrosis is a debilitating and painful disorder with an increased stimulation of the connective tissue in the skin and systemic tissues. The disease is associated with exposure to gadolinium-based contrast agent used in magnetic resonance imaging in patients with renal impairment. METHODS: The prevalence of nephrogenic systemic fibrosis has so far never been determined at a national level. In 2009, Denmark was the first country to design a guideline for the tracing of nephrogenic systemic fibrosis patients. The aim of this paper is to communicate the main findings of this quest. RESULTS: The outcome of the nationwide investigation revealed that Denmark had 65 patients with nephrogenic systemic fibrosis and thereby the highest prevalence of nephrogenic systemic fibrosis worldwide with 65 per 5.6 million inhabitants, or 12 per million. CONCLUSIONS: The nationwide investigation in Denmark revealed the highest prevalence of NSF worldwide. This may be rooted in a high level of awareness of NSF both among doctors, politicians and, not least, the media, combined with the fact that a nationwide NSF investigation was initiated. Public Library of Science 2013-12-09 /pmc/articles/PMC3857209/ /pubmed/24349178 http://dx.doi.org/10.1371/journal.pone.0082037 Text en © 2013 Elmholdt et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Elmholdt, Tina R. Olesen, Anne B. B. Jørgensen, Bettina Kvist, Stinne Skov, Lone Thomsen, Henrik S. Marckmann, Peter Pedersen, Michael Nephrogenic Systemic Fibrosis in Denmark– A Nationwide Investigation |
title | Nephrogenic Systemic Fibrosis in Denmark– A Nationwide Investigation |
title_full | Nephrogenic Systemic Fibrosis in Denmark– A Nationwide Investigation |
title_fullStr | Nephrogenic Systemic Fibrosis in Denmark– A Nationwide Investigation |
title_full_unstemmed | Nephrogenic Systemic Fibrosis in Denmark– A Nationwide Investigation |
title_short | Nephrogenic Systemic Fibrosis in Denmark– A Nationwide Investigation |
title_sort | nephrogenic systemic fibrosis in denmark– a nationwide investigation |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3857209/ https://www.ncbi.nlm.nih.gov/pubmed/24349178 http://dx.doi.org/10.1371/journal.pone.0082037 |
work_keys_str_mv | AT elmholdttinar nephrogenicsystemicfibrosisindenmarkanationwideinvestigation AT olesenannebb nephrogenicsystemicfibrosisindenmarkanationwideinvestigation AT jørgensenbettina nephrogenicsystemicfibrosisindenmarkanationwideinvestigation AT kviststinne nephrogenicsystemicfibrosisindenmarkanationwideinvestigation AT skovlone nephrogenicsystemicfibrosisindenmarkanationwideinvestigation AT thomsenhenriks nephrogenicsystemicfibrosisindenmarkanationwideinvestigation AT marckmannpeter nephrogenicsystemicfibrosisindenmarkanationwideinvestigation AT pedersenmichael nephrogenicsystemicfibrosisindenmarkanationwideinvestigation |